These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1731502)

  • 1. An IgG inhibitor against coagulation factor XIII: resolution of bleeding after plasma immunoadsorption with staphylococcal protein A.
    Gailani D
    Am J Med; 1992 Jan; 92(1):110-2. PubMed ID: 1731502
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide.
    Nakamura S; Kato A; Sakata Y; Aoki N
    Br J Haematol; 1988 Mar; 68(3):313-9. PubMed ID: 3258529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus.
    Ahmad F; Solymoss S; Poon MC; Berube C; Sullivan AK
    Br J Haematol; 1996 Jun; 93(3):700-3. PubMed ID: 8652397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption.
    Matic G; Hofmann D; Winkler R; Tiess M; Michelsen A; Schneidewind JM; Hebestreit G; Keysser M; Müller W; Kinze EM; Ramlow W
    Artif Organs; 2000 Feb; 24(2):103-7. PubMed ID: 10718762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.
    Lorand L; Velasco PT; Rinne JR; Amare M; Miller LK; Zucker ML
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):232-6. PubMed ID: 3422419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in reduction of coagulation factor XIII (F13) between immunoadsorption plasmapheresis and double filtration plasmapheresis.
    Hanafusa N; Noiri E; Nangaku M
    Ther Apher Dial; 2013 Apr; 17(2):241-2. PubMed ID: 23551681
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
    Krumdieck R; Shaw DR; Huang ST; Poon MC; Rustagi PK
    Am J Med; 1991 May; 90(5):639-45. PubMed ID: 1903026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).
    Lorand L; Maldonado N; Fradera J; Atencio AC; Robertson B; Urayama T
    Br J Haematol; 1972 Jul; 23(1):17-27. PubMed ID: 5045959
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracerebral haemorrhage due to acquired factor XIII inhibitor--successful response to factor XIII concentrate.
    Daly HM; Carson PJ; Smith JK
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):507-14. PubMed ID: 1768763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired factor XIII deficiency: a therapeutic challenge.
    Boehlen F; Casini A; Chizzolini C; Mansouri B; Kohler HP; Schroeder V; Reber G; de Moerloose P
    Thromb Haemost; 2013 Mar; 109(3):479-87. PubMed ID: 23306660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advance in immunoadsorption therapy].
    Wang ZG
    Zhonghua Nei Ke Za Zhi; 1993 Nov; 32(11):724-5. PubMed ID: 8137649
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful management of paraprotein-associated peripheral polyneuropathies by immunoadsorption of plasma with staphylococcal protein A.
    Weinstein R; Sato PT; Shelton K; Hartigan N; Ropper AH; Hayes M; Cardillo K
    J Clin Apher; 1993; 8(2):72-7. PubMed ID: 8226708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of immunoadsorption therapy by a protein A column on patients with thrombocytopenia.
    Muroi K; Sasaki R; Miura Y
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):10-4. PubMed ID: 2658094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolization of middle hemorrhoidal artery in the management of life-threatening rectal bleeding.
    Morar KN; Syed MI; Patel JK; Shaikh A
    Cardiovasc Intervent Radiol; 2006; 29(1):128-9. PubMed ID: 16418900
    [No Abstract]   [Full Text] [Related]  

  • 15. Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption.
    Bygren P; Freiburghaus C; Lindholm T; Simonsen O; Thysell H; Wieslander J
    Lancet; 1985 Dec; 2(8467):1295-6. PubMed ID: 2866351
    [No Abstract]   [Full Text] [Related]  

  • 16. [The acute bleeding rectal ulcer].
    Hansen H
    Dtsch Med Wochenschr; 1985 Jun; 110(24):960-2. PubMed ID: 3888597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sengstaken tube for bleeding rectal angiodysplasia.
    Basso L; Ahmed I
    Br J Surg; 1996 Dec; 83(12):1795. PubMed ID: 9038575
    [No Abstract]   [Full Text] [Related]  

  • 18. [Protein A immunoadsorption al a new apheresis procedure for elimination of HLA antibodies].
    Schneidewind J; Gliesche T; Sehland D; Ramlow W; Wolfsdorff B; Bast R; Wegener S; Decker S; Schmidt R
    Beitr Infusionsther Transfusionsmed; 1994; 32():360-5. PubMed ID: 9480125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thalidomide associated to endoscopic treatment with argon plasma coagulation in rectal bleeding caused by vascular injury secundary to severe actinic proctitis].
    Pizarro Moreno A; Garzón Benavides M; Araujo Miguez A; Bozada García JM
    Med Clin (Barc); 2012 Oct; 139(8):369-70. PubMed ID: 22498348
    [No Abstract]   [Full Text] [Related]  

  • 20. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
    Szpirt W; Somnier F; Nielsen FC; Rødgaard A
    Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.